Stay updated with breaking news from High Affinity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A method for finding high-affinity antibody therapeutics that is based on artificial intelligence (AI) has been created by researchers at the University of California San Diego School of Medicine.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug development in rare respiratory diseases,...
/PRNewswire/ -- Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug development in rare respiratory diseases,...
/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical Company focused on oncology, today announced an oral...